126 related articles for article (PubMed ID: 8386504)
21. Sequential morphologic events during apoptosis of human neutrophils. Modulation by lipoxygenase-derived eicosanoids.
Hébert MJ; Takano T; Holthöfer H; Brady HR
J Immunol; 1996 Oct; 157(7):3105-15. PubMed ID: 8816421
[TBL] [Abstract][Full Text] [Related]
22. 5-L-hydroxy-6,8,11,14-eicosatetraenoate potentiates the human neutrophil degranulating action of platelet-activating factor.
O'Flaherty JT; Thomas MJ; Hammett MJ; Carroll C; McCall CE; Wykle RL
Biochem Biophys Res Commun; 1983 Feb; 111(1):1-7. PubMed ID: 6403011
[TBL] [Abstract][Full Text] [Related]
23. Effects of oxo and dihydro metabolites of 12-hydroxy-5,8,10,14-eicosatetraenoic acid on chemotaxis and cytosolic calcium levels in human neutrophils.
Powell WS; Hashefi M; Falck JR; Chauhan K; Rokach J; Wang SS; Mills E; MacLeod RJ
J Leukoc Biol; 1995 Feb; 57(2):257-63. PubMed ID: 7852839
[TBL] [Abstract][Full Text] [Related]
24. Arachidonic acid and 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid modulate human polymorphonuclear neutrophil activation by monocyte derived neutrophil activating factor.
Smith RJ; Sam LM; Justen JM; Bundy GL; Fitzpatrick FA; Wynalda MA
Biochem Biophys Res Commun; 1987 Oct; 148(2):636-45. PubMed ID: 2825667
[TBL] [Abstract][Full Text] [Related]
25. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
Williams JD; Lee TH; Lewis RA; Austen F
J Immunol; 1985 Apr; 134(4):2624-30. PubMed ID: 2982947
[TBL] [Abstract][Full Text] [Related]
26. Interaction of human neutrophils with airway epithelial cells: reduction of leukotriene B4 generation by epithelial cell derived prostaglandin E2.
Klockmann MT; Jahn HU; Hippenstiel S; Krämer HJ; Suttorp N
J Cell Physiol; 1998 Jun; 175(3):268-75. PubMed ID: 9572471
[TBL] [Abstract][Full Text] [Related]
27. Activation of neutrophil chemotaxis by leukotriene B4 and 5-hydroxyeicosatetraenoic acid in chronic inflammatory bowel disease.
Nielsen OH; Elmgreen J
Scand J Clin Lab Invest; 1987 Oct; 47(6):605-11. PubMed ID: 2823370
[TBL] [Abstract][Full Text] [Related]
28. Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes.
Lärfars G; Lantoine F; Devynck MA; Palmblad J; Gyllenhammar H
Blood; 1999 Feb; 93(4):1399-405. PubMed ID: 9949184
[TBL] [Abstract][Full Text] [Related]
29. SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells.
Kemény L; Ruzicka T
Agents Actions; 1991 Mar; 32(3-4):339-42. PubMed ID: 1650525
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms involved in the bidirectional effects of protein kinase C activators on neutrophil responses to leukotriene B4.
O'Flaherty JT; Redman JF; Jacobson DP
J Immunol; 1990 Mar; 144(5):1909-13. PubMed ID: 2155269
[TBL] [Abstract][Full Text] [Related]
31. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils.
O'Flaherty JT; Nishihira J
J Immunol; 1987 Mar; 138(6):1889-95. PubMed ID: 3029224
[TBL] [Abstract][Full Text] [Related]
32. Metabolism and biologic effects of 5-oxoeicosanoids on human neutrophils.
Powell WS; MacLeod RJ; Gravel S; Gravelle F; Bhakar A
J Immunol; 1996 Jan; 156(1):336-42. PubMed ID: 8598482
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human neutrophils.
Powell WS; Gravelle F; Gravel S; Hashefi M
J Lipid Mediat; 1993; 6(1-3):361-8. PubMed ID: 8395251
[TBL] [Abstract][Full Text] [Related]
34. Activation of the human neutrophil 5-lipoxygenase by leukotriene B4.
McDonald PP; McColl SR; Naccache PH; Borgeat P
Br J Pharmacol; 1992 Sep; 107(1):226-32. PubMed ID: 1330161
[TBL] [Abstract][Full Text] [Related]
35. The in vitro and in vivo pharmacologic activity of the potent and selective leukotriene B4 receptor antagonist CP-105696.
Showell HJ; Pettipher ER; Cheng JB; Breslow R; Conklyn MJ; Farrell CA; Hingorani GP; Salter ED; Hackman BC; Wimberly DJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):176-84. PubMed ID: 7714764
[TBL] [Abstract][Full Text] [Related]
36. Enhanced generation of leukotriene B4 by neutrophils stimulated by unopsonized zymosan and by calcium ionophore after exercise-induced asthma.
Arm JP; Horton CE; House F; Clark TJ; Spur BW; Lee TH
Am Rev Respir Dis; 1988 Jul; 138(1):47-53. PubMed ID: 2849339
[TBL] [Abstract][Full Text] [Related]
37. Amplification of LTB4 generation in AM-PMN cocultures: transcellular 5-lipoxygenase metabolism.
Grimminger F; Sibelius U; Seeger W
Am J Physiol; 1991 Aug; 261(2 Pt 1):L195-203. PubMed ID: 1651667
[TBL] [Abstract][Full Text] [Related]
38. Requirement of free arachidonic acid for leukotriene B4 biosynthesis by 12-hydroperoxyeicosatetraenoic acid-stimulated neutrophils.
Kanaji K; Okuma M; Sugiyama T; Sensaki S; Ushikubi F; Uchino H
Biochem Biophys Res Commun; 1986 Jul; 138(2):589-95. PubMed ID: 3017333
[TBL] [Abstract][Full Text] [Related]
39. Lung cancer cell lines inhibit leukotriene B4 production by human polymorphonuclear leukocytes at the level of phospholipase A2.
Abe M; Matsuki H; Domae M; Kuwata H; Kudo I; Nakanishi Y; Hara N; Mitsuyama T; Furukawa T
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):565-73. PubMed ID: 8918363
[TBL] [Abstract][Full Text] [Related]
40. The leukotriene B4 paradox: neutrophils can, but will not, respond to ligand-receptor interactions by forming leukotriene B4 or its omega-metabolites.
Haines KA; Giedd KN; Rich AM; Korchak HM; Weissmann G
Biochem J; 1987 Jan; 241(1):55-62. PubMed ID: 3032161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
